- Research works
- 48 ▼ 59% vs 2013–17
- Citations
- 1.2k 25.4 per fractional work
- Top-10% rate
- 14.5% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Dr Falk Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
Who are the top researchers at Dr Falk Pharma (Germany)?
Ranked on the composite score, Roland Greinwald lead among researchers whose main affiliation is Dr Falk Pharma (Germany).
- 1 Roland Greinwald Germany · #1,116,791 worldwide 18 citations · 26 works
Which keywords describe research at Dr Falk Pharma (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Management, Inflammatory Bowel Disease, Pathogenesis, Treatment, Guidelines and Children.
- Glaucoma
- Celiac Disease
- Intestinal Permeability
- Multidrug Resistance
- Primary Biliary Cirrhosis
- Chemotherapy
- NASH
- Hepatocellular Carcinoma
- Hepatic Steatosis
- Metabolic Syndrome
- Epidemiological Study
- Liver Transplantation
- Ulcerative Colitis
- Histologic Remission
- Crohn's Disease
- Adults
- Children
- Treatment
- Inflammatory Bowel Disease
- Diagnosis
- Epidemiology
- Management
- Pathogenesis
- Guidelines
- Genetics
- Immunology
- Eosinophilic Esophagitis
- Therapies
- Inflammation
- Proton Pump Inhibitors
- Insulin Resistance
- Collagenous Colitis
- Microscopic Colitis
- NAFLD
- Immunosuppressive Therapy
- Autoimmune Hepatitis
- ATP-dependent Transporters
- Risk Factors
- Prevalence
- Genetic Variants
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology13▲ 6.7×24 topics
- Diagnosis8▲ 16×12 topics
- Management8▲ 21×11 topics
- Inflammatory Bowel Disease7▲ 129×4 topics
- Pathogenesis6▲ 23×5 topics
- Treatment5▲ 8.1×13 topics
- Guidelines4▲ 19×4 topics
- Children4▲ 33×5 topics
- Genetics4▲ 11×4 topics
- Adults4▲ 104×2 topics
- Immunology4▲ 64×2 topics
- Crohn's Disease4▲ 93×2 topics
- Eosinophilic Esophagitis4▲ 254×1 topic
- Histologic Remission4▲ 254×1 topic
- Therapies4▲ 210×1 topic
- Ulcerative Colitis4▲ 210×1 topic
- Inflammation3▲ 2.9×12 topics
- Liver Transplantation3▲ 43×4 topics
- Proton Pump Inhibitors3▲ 75×2 topics
- Epidemiological Study3▲ 73×2 topics
- Insulin Resistance3▲ 12×3 topics
- Metabolic Syndrome3▲ 6.6×4 topics
- Collagenous Colitis3▲ 208×1 topic
- Hepatic Steatosis3▲ 36×2 topics
- Microscopic Colitis3▲ 208×1 topic
- Hepatocellular Carcinoma2▲ 24×2 topics
- NAFLD2▲ 47×1 topic
- NASH2▲ 47×1 topic
- Immunosuppressive Therapy2▲ 26×3 topics
- Chemotherapy2▲ 6.7×10 topics
- Autoimmune Hepatitis2▲ 229×1 topic
- Primary Biliary Cirrhosis2▲ 229×1 topic
- ATP-dependent Transporters2▲ 76×1 topic
- Multidrug Resistance2▲ 66×1 topic
- Risk Factors2▲ 3.5×5 topics
- Intestinal Permeability2▲ 66×2 topics
- Prevalence2▲ 8.2×3 topics
- Celiac Disease1▲ 149×1 topic
- Genetic Variants1▲ 12×2 topics
- Glaucoma1▲ 16×3 topics
Which research topics does Dr Falk Pharma (Germany) publish most on?
By volume in 2022–2025: Eosinophilic Esophagitis, Inflammatory Bowel Disease, Receptor Mechanisms and Signaling and Gastric Cancer Management and Outcomes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Eosinophilic Esophagitis Surgery 2 works
- 2 Inflammatory Bowel Disease Genetics 0 works
- 3 Receptor Mechanisms and Signaling Molecular Biology 0 works
- 4 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
- 5 Drug Transport and Resistance Mechanisms Oncology 0 works
- 6 Esophageal and GI Pathology Surgery 0 works
- 7 Colorectal Cancer Treatments and Studies Oncology 0 works
- 8 Eosinophilic Disorders and Syndromes Rheumatology 0 works
- 9 Gastroesophageal reflux and treatments Gastroenterology 0 works
- 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Dr Falk Pharma (Germany)'s research output changed?
Output in 2018–2022 was 59% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Freiburg im Breisgau
- University of Freiburg
- University Medical Center Freiburg
- Klinik für Frauenheilkunde
- Fraunhofer Institute for Solar Energy Systems
- Fraunhofer Institute for Applied Solid State Physics
- Max Planck Institute for the Study of Crime, Security and Law
- Max Planck Institute of Immunobiology and Epigenetics
- University of Education Freiburg
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.